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Trichloroethylene  (TCE)  is  widely  used  as a  metal  degreaser  in  industrial  processes.  The
present  study  reports  on the effects  of  TCE  exposure  on workers  employed  in the  lock
industries.  To  ensure  exposure  of  the  workers  to TCE,  its  toxic  metabolites,  trichloroacetic
acid (TCA),  dichloroacetic  acid  (DCA)  and  trichloroethanol  (TCEOH)  were  detected  in the
plasma of the  subjects  through  solid  phase  microextraction-gas  chromatography-electron
capture  detection.  TCA, DCA  and  TCEOH  were  detected  in the  range  of 0.004–2.494  g/mL,
0.01–3.612  g/mL  and  0.002–0.617  g/mL,  respectively.  Quantitative  reverse  transcrip-
tion  polymerase  chain  reaction  analysis  revealed  up-regulated  expression  of  p53  (2.4-fold;
p <  0.05),  p21  (2-fold;  p  < 0.01),  bax  (2.9-fold;  p < 0.01)  mRNAs  and  down-regulated
expression  of bcl-2  (67%;  p  <  0.05)  mRNAs,  indicating  DNA  damaging  potential  of these
metabolites.  No  effects  were  observed  on  the  levels  of p16 and  c-myc  mRNAs.  Further,
as TCA  and DCA,  the  ligand  of  peroxisome  proliferator  activated  receptor  alpha  (PPARA),
are  involved  in the  process  of hepatocarcinogenesis  in  rodents,  we  examined  expression
of  PPARA  mRNA  and  let-7c  miRNA  in  the workers.  No  statistically  signiﬁcant  differences
in  expression  of PPARA  mRNA  and  let-7c  miRNA  in patients  were  observed  as  compared
to  values  in  controls.  Dehydroepiandosterone  sulfate  (DHEAS)  is  a reported  endogenous
ligand  of  PPARA  so  its co
of  DHEAS  hormone  in the
changes  in the  levels  of va
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. Introduction
Increasing rate of industrialization is posing potential
ealth hazards to workers due to accumulation of harmful
hemicals in the environment. Trichloroethylene (TCE) is
 lipophilic and volatile organic solvent, which is haphaz-
rdly used in India as a part of commercial enterprises for
etal degreasing processes. Epidemiological studies have
uggested a correlation between TCE exposure and non-
odgkin’s lymphoma, liver, renal, and biliary tract cancers
1]. TCE has become an occupational hazard. This study was
erformed on workers of small scale industries of Aligarh
ity located in Uttar Pradesh, an Indian state where locks
nd keys are manufactured.
The U.S. Environmental Protection Agency (EPA) char-
cterized TCE as “carcinogenic to humans” in 2011 [46],
lthough there is no convincing evidence indicating its
enotoxicity in vitro [2]. TCE is known to exert its hepato-
oxic and carcinogenic effects primarily through metabolic
ctivation [3]. TCE metabolism occurs through two major
athways: cytochrome P450 (CYP) dependent oxidation
nd glutathione (GSH) conjugation pathway. GSH-derived
etabolites of TCE are known to be mutagenic [4].
oore and Harrington-Brock [5] advocated requirement
f very high doses of its metabolites to induce genotoxic
ffects. Different studies have shown that the oxidative
etabolites of TCE, speciﬁcally trichloroacetic acid (TCA),
ichloroacetic acid (DCA) and trichloroethanol (TCEOH)
lso cause DNA damage [6–9]. DNA damaging agents have
een documented to alter the expression of several genes
ssociated with cell cycle, tumor suppression or induction
oncogenes) and apoptosis. DNA damage induces expres-
ion of p53, a tumor suppressor protein that regulates
ell cycle progression check point G1-S transition. p53 can
rrest the cell cycle at the G1 check point to avoid replica-
ion of damaged DNA and/or to lead to apoptosis [10,11].
53 also induces the expression of the cyclin-dependent
inase inhibitor p21. p53-controlled p21 expression in
esponse to DNA damage blocks cell cycle progression into
he S-phase [12]. p16, a cyclin-dependent-kinase inhibitor,
s also a tumor suppressor protein that checks the cell cycle
n the early G1 phase and inhibits transition of the cell cycle
rom G1 to S phase, as a component of a multi-protein regu-
atory complex. c-myc, a proto-oncogene, is a transcription
actor that participates in the control of cell proliferation
nd apoptosis. p53 and c-myc are involved in many similar
ellular processes, affecting similar targets and regulat-
ng one another’s action [13]. Apoptosis in cells is also
egulated through bcl-2 family protein members. Among
hese protein members, bax and bcl-2 physically interact
ith each other and form the homo- and heterodimers
cl-2/bcl-2, bcl-2/bax and bax/bax. The bax homodimers
romote apoptosis, and bax-mediated cell death is checked
y bcl-2/bax heterodimerization [14]. p53 up-regulates bax
ene expression and down-regulates bcl-2 gene expression
n association with genotoxic stress.
TCE is reported to have similar metabolic pathways
n humans, rats, and mice. However sex-, species-, and
train-speciﬁc differences in the rates of metabolism
etermine the susceptibility to TCE [15,16]. The acidic
etabolites of TCE, TCA and DCA, act via peroxisomeports 2 (2015) 748–757 749
proliferator-activated receptor (PPAR), a ligand-activated
transcription factor belonging to the steroid receptor
superfamily. They interact with the alpha isoform of PPAR,
resulting into peroxisome proliferation in rodents and liver
carcinoma. In spite of the fact that TCA and DCA are
considered hepatocarcinogens in rodents [42,17–21], the
aspects of their impact on humans are obscure. Dehy-
droepiandosterone sulfate (DHEAS) is acknowledged as an
endogenous PPAR activator. DHEAS, a sulfate ester of DHEA
and having peroxisome proliferative potential in rodents,
is one of the most abundant and multifunctional steroids
in humans [22]. However, the underlying cellular mech-
anisms of DHEAS in peroxisome proliferation in rats are
unclear.
Micro RNAs represent a class of noncoding, small RNAs
that regulate gene expression. They mostly induce mRNA
degradation and translational repression by binding to
the 3′-untranslated regions (3′UTR) of the target mRNAs
[23,24]. In recent studies, miRNAs have been noted to par-
ticipate in hepatocarcinogenesis [25,26]. Among all human
cancer-related miRNAs, the let-7 family of miRNAs has
been observed to be aberrantly expressed and play pivotal
roles in tumorigenesis [44]. Among members of the let-7
family miRNAs, let-7c has been found to be associated with
PPARA-agonist incited liver proliferation and tumorigene-
sis in mice [27].
We have focused our studies toward the occupational
health hazard of TCE and investigated the underlying
mechanism of the interaction between TCE metabolites
(TCA/DCA) and PPARA and the potential role of miRNA
let-7c in these events. In addition, we  have investigated a
connection between TCE exposure and levels of the DHEAS
hormone in lock industry workers.
2. Materials and methods
2.1. Chemicals
Trichloroacetic acid (TCA; CAS No. 76-03-9; ≥99%pure),
chloroform, isopropanol and ethanol were purchased from
Sigma Aldrich (St. Louis, MO,  USA). Dichloroacetic acid
(DCA; CAS No.79-43-6; ≥98.0% pure), trichloroethanol
(TCEOH; CAS No.115-20-8), methyl chloroformate (MCF;
CAS No. 79-22-1), pyridine (CAS No. 110-86-1), methanol,
and NaCl were procured from Merck Chemicals (Darm-
standt, Germany). Trizol reagent was purchased from
Invitrogen Bioservices India Pvt. Ltd. (Bangalore, India).
Material related to solid-phase microextraction (SPME),
such as polydimethylsiloxane (PDMS) ﬁber of 100 m ﬁlm
thickness, SPME vials, septa, holder and heating block were
supplied by Supelco (Bellefonte, PA, USA).
2.2. Selection of subjects
The study population consisted of 68 male workers. A
total of 49 workers were employed in the metal degreas-
ing process in the lock industries of Aligarh (West UP, India)
and were exposed to trichloroethylene (TCE). This group of
workers was  considered an exposed group. Out of 49 work-
ers 19 workers with comparable socioeconomic status and
demographic proﬁle, employed in assembling of locks,
ology Re750 M. Varshney et al. / Toxic
were included in the study as the control group. Detailed
information regarding socioeconomic status, family his-
tory, education, personal habits, health status and exposure
to TCE were recorded for each subject in a pre-tested ques-
tionnaire. The questionnaire was both in English and Hindi
(local language) and investigators recorded all the infor-
mation. The purpose of the study was explained to all
the participants and prior to the study, written consent
was obtained from each subject. Ethical clearance from the
Institutional Human Ethics committee of Indian Institute
of Toxicology Research (IITR) was also obtained.
2.3. Lung function studies
Lung function tests, including Peak Expiratory Flow rate
(PEFR) and Forced Expiratory Volume in one sec (FEV1),
were performed using a calibrated spirometer (PIKO-1, UK,
under the recommendation of the American Thoracic Soci-
ety standards) in a standing position for each subject. The
volunteer performed the lung function test three times,
allowing for sufﬁcient rest between repetitions. The best
values for PEFR and FEV1 from three tests for each subject
were recorded.
2.4. Body composition monitoring
Height was measured without shoes in an erect position
using a stadiometer and rounded down to the nearest cen-
timeter. Body mass index (BMI), weight and body fat % were
measured using body fat monitor HBF 352 (Omron Co., Ltd.,
Kyoto, Japan) and rounded up to the nearest kilogram based
on bioelectric impedance analysis (BIA).
2.5. Blood sample collection
The sampling of biological material was carried out
according to the Helsinki Declaration and under the super-
vision of experts. Approximately 2–3 mL  of blood was
collected from both the control and exposed groups. Blood
samples were collected in EDTA-coated vacutainers, BD
serum vacutainers (BD Biosciences, Becton Drive Franklin
Lakes, New Jersey, USA), tubes containing Trizol and lysis
buffer to perform various analyses. Samples kept in ice
were immediately transported to the biochemical labora-
tory of the Aligarh Muslim University of Aligarh. Plasma
and serum separation was carried out on the same day
and stored. All the samples were stored at −80 ◦C until
processing was started.
2.6. Measurement of TCE metabolites in plasma
The TCE metabolites TCA, DCA and TCEOH were mea-
sured in the plasma of control and exposed groups.
Plasma was separated from the blood after centrifugation
at a speed of 1200 rpm (241 × g) and collected in sepa-
rate centrifuge tubes for analysis. Stock solutions of TCE
metabolites were individually prepared in ultrapure water
produced from a Milli-Q water puriﬁcation system (Mil-
lipore, Bedford, MA,  USA) at a concentration of 1 mg/mL.ports 2 (2015) 748–757
A working mix  standard was  prepared by diluting stock
solutions of DCA, TCEOH and TCA accordingly.
2.7. In-matrix derivatization and SPME
In-matrix derivatization was  based on a previously
reported procedure [28]. Brieﬂy, 100 L of plasma sam-
ple was diluted up to 1 mL  with methanol/water (1:1; v/v).
To this mixture, 200 L of pyridine was  added as a cat-
alyst for in-matrix derivatization followed by addition of
300 L of MCF  (150 L × 2 times). The reaction mixture was
mixed for 30 s on a vortex mixer to ensure complete deriva-
tization. The derivatized sample was  then transferred to
a SPME (solid-phase microextraction) vial and diluted up
to 3 mL  with ultrapure water. At this stage 562.5 mg  of
NaCl was  added to enhance the ionic strength of the sam-
ple. Prior to extraction, the SPME ﬁbers were conditioned
at 250 ◦C for 30 min  as recommended by the manufac-
turer. The sample was then exposed to SPME ﬁber (PDMS,
100 m)  for 22 min  at 50 ◦C. After the adsorption of non-
polar MCF  derivatives of TCE metabolites, the SPME ﬁbers
were injected into the GC-ECD injector port for desorption
of analytes at 200 ◦C for 1 min.
2.8. Chromatographic conditions
Analysis of TCE metabolites was carried out on a
Perkin Elmer Clarus 500 gas chromatograph equipped
with an electron capture detector (ECD). Separation was
achieved on a DB-5 capillary column (5% phenyl–95%
methylpolysiloxane; 30 m length × 0.25 mm I.D. × 0.25 m
ﬁlm thickness). Nitrogen (99.99%) was used as a carrier
gas at a ﬂow rate of 1 mL/min and also as a makeup gas
for ECD at a ﬂow rate of 30 mL/min. ECD was  operated at
375 ◦C. Oven temperature programming was as follows:
initial 80 ◦C (no hold), increased to 100 ◦C at the rate of
2 ◦C/min (hold for 3 min), and further increased to 280 ◦C at
the rate of 45 ◦C/min (hold for 5 min; total run time 22 min).
Desorption of analytes from SPME ﬁbers was achieved at an
injector port temperature of 200 ◦C (split 1:5).
2.9. Quantitative determination of DHEAS in human
serum
For serum separation, the blood was  collected in a
BD serum vacutainer and allowed to coagulate by keep-
ing the vials in a slanted position at room temperature.
The whitish-colored upper layer that contained serum was
aspirated. DHEAS (Dehydroepiandosterone sulphate) hor-
mone level was  measured in serum of both the control
and exposed subjects with a DHEAS Elisa kit (Alpha diag-
nostic International, San Antonio, Texas, USA) as per the
manufacturer’s instructions.
2.10. PPARA and cell cycle regulating gene expression
analyses using reverse transcriptase polymerase chain
reaction
Each subject was analyzed three times for gene expres-
sion study following the procedures described below.
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.10.1. RNA extraction
Total RNA was extracted from blood of control (n = 19)
nd TCE-exposed persons (n = 49) with Trizol reagent using
he standard protocol as described by Chomczynski and
acchi [29]. Brieﬂy, in 2 mL  centrifuge tubes 100 L of blood
nd 600 L of Trizol was added. Then 120 L of chloroform
as added and the contents were incubated for 15 min
t 37◦C. Contents were centrifuged at 12,000 rpm at 4◦C
or 10 min. Addition of chloroform followed by centrifuga-
ion separated the solution into an aqueous phase and an
rganic phase. The aqueous phase was transferred to a new
ube and 500 L of isopropanol was added and then incu-
ated for 10 min  at room temperature. The solution was
entrifuged at 12,000 rpm at 4◦C for 10 min. Centrifugation
esulted in the formation of a white pellet that contained
NA. Supernatant was discarded and the pellet was washed
ith 70% ethanol. The pellet was air-dried and dissolved in
EPC-treated water. Quality and quantity of RNA samples
ere checked with a Picodrop spectrophotometer.
.10.2. Quantitative RT PCR (qRT-PCR) analysis
cDNA was synthesized using total RNA (500 ng) and a
igh Capacity cDNA Reverse Transcriptase kit (ABI, Sta-
ey Road, Grand Island, New York, USA) according to the
anufacturer’s protocol. 2X RT master mixes were pre-
ared on ice according to the manufacturer’s instructions.
he reaction mixture, containing 1X RT buffer, 8 mM dNTP
ix, 1X RT random primers and 1 L each of Multiscribe
everse transcriptase and RNAs inhibitor in a total vol-
me  of 10 L, was mixed gently. RNA (10 L, 500 ng) was
dded to 10 L of 2X RT master mix. The total volume of
he reaction mixture in the tube was 20 L. Brieﬂy, the
ube was centrifuged and loaded on to a thermal cycler
DNA Engine, M.  J. Research, Minnesota, USA) programmed
or 10 min  at 25◦C, 120 min  at 37◦C and 5 min  at 85◦C.
he ampliﬁcation of genes was carried out in a real-time
CR machine using SYBR green-based chemistry. The reac-
ion mixture (20 L) was prepared containing 1X SYBR
reen master mix, 0.5 M of both forward primers (FP)
nd reverse primers (RP), and 1 L of cDNA. The -actin
ene was used as an internal control. Sequences of the
rimers used for various genes were as follows: -actin,
P 5′-CCTCTATGCCAACACAGT-3′, RP 5′-AGCCACCAATCCA
ACAG-3′; PPARA, FP 5′-ATCAGCCACACCTTTTCCAG-3′, RP
′-ACCCCCAGCATTTGAGTTC-3′; p53, FP 5′-TGGCCCCTGTC
TCTTCTG-3′, RP 5′-CCGTCATGTGCTGTGACTGC-3′; p21,FP
′-TGAGCGATGGAACTTCGACT-3′, RP 5′-GACAGTGACAGGT
CACATGG-3′; bax, FP 5′-ATGGACGGGTCCGGGGAG-3′, RP
′-ATCCAGCCCAACAGCCGC-3′; bcl-2, FP 5′-AAGCCGGCGA
GACTTCT-3′, RP 5′-GGTGCCGGTTCAGGTACTCA-3′; p16,
P 5′-CCCGCTTTCGTAGTTTTCAT-3′, RP 5′-TTATTTGAGCTTT
GTTCTG-3′, and c-myc FP 5′-CCAACAGGAGCTATGACCTC-
′, RP 5′-CTCGGTCACCATCTCCAG-3′. Samples were loaded
n the real-time PCR machine and the program was  run
ith thermal cycling conditions as follows: For the -actin
ene – 10 min  at 95◦C, 30 cycles of 30 s at 95◦C, 40 s at 59◦C
nd 30 s at 72◦C; for the PPARA gene – 10 min  at 95◦C, 45
ycles of 15 s at 95◦C, 60 s at 62◦C and 15 s at 72◦C; for the
53 and bcl-2 genes – 10 min  at 95◦C and 32 cycles of 45 s
t 95◦C, 35 s at 65◦C and 60 s at 72◦C; for the p21 gene –
0 min  at 95◦C and 32 cycles of 45 s at 95◦C, 30 s at 63◦Cports 2 (2015) 748–757 751
and 50 s at 72◦C; for the bax gene – 10 min  at 95◦C and 32
cycles of 45 s at 95◦C, 45 s at 71◦C and 15 s at 72◦C; for the
p16 gene – 10 min at 95◦C and 32 cycles of 15 s at 95◦C, 15 s
at 62◦C and 15 s at 72◦C; and for the c-myc gene – 10 min
at 95◦C and 32 cycles of 45 s at 95◦C, 35 s at 52◦C and 60 s
at 72◦C. Relative quantiﬁcation was done by means of the
−Ct method.
2.11. let-7c miRNA expression proﬁling
The total RNA containing small RNAs was isolated using
mirVana miRNA isolation kit (Invitrogen Bioservices India
Pvt. Ltd., Bangalore, India) as described by the manufac-
turer. After RNA isolation, reverse transcription was carried
out using reverse transcriptase primers of hsa-let-7c assay
ID 000379 and RNU 44 assay ID 001094 (ABI, Staley Road,
Grand Island, New York, USA). RNU 44 miRNA was  used
as reference control. RT was  performed with the Taqman
miRNA reverse transcription kit from ABI, as described
by the manufacturer. In brief, 15 L of reaction mixture
contained 1X RT buffer, 15 mM  dNTPs, 3.8 units of RNAs
inhibitor, 50 cells of Multiscribe RT enzyme and 50 ng total
RNA. The thermal cycling conditions used for reverse tran-
scription were 30 min  at 16◦C, 30 min  at 42◦C and 5 min  at
85◦C. After reverse transcription, ampliﬁcation was  carried
out using TaqMan probe base chemistry. The PCR reaction
mixture (20 L) contained 1X Taqman microRNA assay,
Taqman 1X universal PCR master mix  without UNG and
1.33 L RT reaction product. The thermal cycling conditions
used for ampliﬁcation were 10 min  at 95◦C, 40 cycles of 15 s
at 95◦C and 60 s at 60◦C. Relative quantiﬁcation was  carried
out by means of −Ct method considering the levels of
RNU 44 as endogenous control.
2.12. Statistical analysis
A student’s t-test and 2 test were applied to compare
the socio-demographic variables between TCE exposed
persons and control group. The student’s t-test was
employed to compare the level of hormone and expres-
sion of gene. The correlation was  detected between
age and DHEAS level in the exposed group. The results
were analyzed using Prism version 5, Graph Pad Soft-
ware Inc. Values of p < 0.05 were considered statistically
signiﬁcant.
3. Results
3.1. Study population characteristics
Physical characteristics of the study population are
depicted in Table 1 and no signiﬁcant differences were
found between the exposed and control group except the
weight of the exposed workers that was  lower than that of
workers in control group (p ≤ 0.05). Workers in the factory
were exposed to TCE for an average of 36.6 ± 15.3 years
(mean ± SD). Table 2 illustrates outcomes of physical tests
performed in both groups to be acquainted with health sta-
tus. BMI  and body fat percent of study subjects was in the
normal range, although there was  a signiﬁcant difference
between exposed and controls (p < 0.05). Lung function test
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Table 1
Distribution of physical and socio-demographic variables in TCE exposed and control group.
Variables Control (n = 19) Exposed (n = 49) p-value
Age (years) {Mean ± SD} 36.57 ± 15.3 34.59 ± 15.6 0.36a
Height (cm) {Mean ± SD} 168.94 ± 7.09 164.57 ± 6.02 0.06a
Weight (kg) {Mean ± SD} 65.26 ± 13.62 53.9 ± 10.6 0.0017a***
Alcohol intake {n(%)}
Non-alcoholic 15 (78.95) 30 (61.22) 0.16b
Alcoholic 4 (21.05) 19 (38.78)
Marital status {n(%)}
Bachelor 12 (63.16) 21 (42.86) 0.13b
Married 7 (36.84) 28 (57.14)
Education {n(%)}
Literate 16 (22.2) 29 (34.28 0.05b*
Illiterate 3 (77.78) 20 (65.72)
Socioeconomic status {n(%)}
High 0 0 0.16b
Middle 14 (84.21) 27 (55.1)
Low 5 (15.79) 22 (44.9)
Dietary habit {n(%)}
Vegetarian 4 (21.05) 9 (18.37) 0.80b
Non-vegetarian 15 (78.95) 40 (81.63)
Exposure (years) {Mean ± SD} 0 12 ± 9.88
a p-value based on Student’s t test for difference in the distributions between groups.
roups.b p-value based on 2 test for difference in the distributions between g
Number in () refer to percentage.
*p ≤ 0.05, ***p ≤ 0.001 statistically signiﬁcant from control.
was performed using an electronic spirometer. Pulmonary
function measurements included peak expiratory ﬂow rate
(PEFR) and forced expiratory volume after 1 s (FEV1). A
highly signiﬁcant decline in PEFR was observed among
exposed subjects compared to control subjects (p < 0.001).
FEV1 also showed signiﬁcant reduction (p < 0.01) in the
exposed subjects compared to the controls.
3.2. TCE metabolites in blood
The TCE metabolites TCA, DCA and TCEOH were
detected in the plasma of all subjects (Table 3). The con-
trol group showed the absence of metabolites in plasma
while TCA was detected in 15 exposed workers and the TCA
concentration ranged from 0.004 to 2.494 g/mL. DCA was
detected in the plasma of 15 exposed workers in the range
of 0.01–3.612 g/mL. TCEOH was found in the plasma of
13 workers ranging from 0.002 to 0.617 g/mL. Five of the
exposed workers were identiﬁed as having TCA, DCA and
TCEOH traces in their blood, and the level was compara-
tively higher than other metabolites. Substantial levels of
these metabolites were present in the plasma sample of
subjects 4 and 10, having 5 and 9 years of TCE exposure,
respectively. On the other hand, subjects 8 and 17 had the
highest concentration of TCA and DCA of those that showed
the presence of either TCA or DCA.
Table 2
Characteristics of selected exposure variables in TCE exposed and controls.
Variable Control (n = 19) 
BMI  22.84 ± 4.16 
Body  fat% 23.20 ± 7.09 
PEFR(Lt/min) 440.08 ± 102.28 
FEV1  (Lt) 1.83 ± 0.58 
Abbreviations: BMI  – Basal metabolic index, PEFR – Peak expiratory ﬂow rate, FE
based on Student’s t-test, *p ≤ 0.05, **p  ≤ 0.01 statistically signiﬁcant from contro3.3. Effect of TCE exposure on p53, p21, bax, bcl-2, p16
and c-myc mRNA expression
mRNA expression analysis of p53, p21, bax, bcl-2, p16
and c-myc genes was  carried out in TCE exposed and con-
trol groups. Quantitative reverse transcription (qRT)-PCR
analysis revealed up-regulation of expression of p53 (2.4-
fold; p < 0.05), p21 (2-fold; p < 0.01), and bax (2.9-fold;
p < 0.01) concomitant with the down-regulation of bcl-2
(67%; p < 0.05) in the exposed individuals in comparison to
the controls as shown in Fig. 1. In contrast, the expression
level of p16 and c-myc genes in the exposed group was not
statistically signiﬁcant as compared to the control values.
3.4. Effect of TCE exposure on mRNA levels of PPARA and
miRNA let-7c expression
The level of PPARA mRNA expression was  nearly 2.5-
fold higher in the exposed group in comparison to the
control group but the difference was  statistically non-
signiﬁcant due to the extent of variation (Fig. 2). miRNA
expression analysis was  also carried out in both groups.
No signiﬁcant difference was  observed in miRNA let-7c
expression level in the exposed workers and control per-
sons.
Exposed (n = 49) p-value#
20.09 ± 4.09 0.0157*
18.23 ± 7.1 0.0129*
318.19 ± 120.53 0.0057**
1.47 ± 0.40 0.0378*
V1 – Forced expiratory volume after 1 s. Results are mean ± SD. #p-value
l.
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Table  3
Plasma was  separated from the blood samples. They were extracted and derivatized for analysis by gas chromatography with electron capture detector.
Subject Exposure (years) TCE metabolites (g/mL)
TCA DCA TCEOH
1 35 0.216 0 0.475
2  8 0.004 0 0
3  6 0.012 0 0
4  9 1.969 1.262 0.617
5  22 0.233 0.057 0.149
6  6 0.332 0 0.023
7  7 0.123 0 0
8  5 2.494 0 0
9  7 0.04 0 0
10  5 1.417 0.534 0.26
11  6 0 0.249 0.106
12  11 0.02 0 0.311
13  15 0.517 0 0
14  4 0.246 0.161 0
15 4 0.333 0.163 0.114
16  40 0 0.747 0
17  20 0 3.612 0
18  7 0 0.194 0
19  25 0 0.07 0.065
20  6 0.022 0.01 0.007
21  5 0 0.448 0
22  20 0 0.063 0
23  17 0 0.163 0
24  14 0 0.112 0
0 
0 
0 
3
e
F
e
w
c
i
c25  4 
26  35 
27  12 
.5. TCE-induced endocrine disruption
Inhibition of DHEAS production in TCE-exposed work-
rs and its comparison with the controls is summarized in
ig. 3 (A and B). After restricting statistical analysis to the
xposed group, the age of the workers and DHEAS levels
ere found to be signiﬁcantly different but with a negative
orrelation (R2 = 0.252, p < 0.001, Fig. 3). There was a signif-
cant decrease in the DHEAS level of the exposed group in
omparison to the control group. Table 4 shows the mean
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Fig. 1. Expression proﬁling of cell cycle regulating genes 0 0.94
0 0.002
0 0.548
hormonal levels with years of exposure. Decrease in DHEAS
concentration was  signiﬁcantly correlated with the years
of TCE exposure. Workers exposed to TCE for ≤5 years to
40 years showed consistent decline in DHEAS level from
2334.20 ng/mL to 1767.32 ng/mL, respectively.4. Discussion
We  assessed the effects of TCE on the health of the
workers employed in lock industries through lung function
p16 cmyc
Control
Exposed
by qRT-PCR in control and TCE exposed persons.
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ExposedFig. 2. Expression proﬁling of PPARA mRNA and miRNA let-7c by qRT-PCR
in  control and TCE exposed persons.
tests and body composition monitoring. To the best of our
knowledge, there are no earlier studies that have been car-
ried out on the occupational exposure to TCE leading to
lung function abnormalities, especially PEFR and FEV1. The
inﬂuence of body composition factors on the lung function
test parameters was ruled out among the study subjects
based on the normal BMI  and body fat (%) observed among
them. The considerable decline in PEFR and FEV1 denote
upper and smaller airway obstruction among the exposed
subjects. The exposure to TCE can lead to bronchiolar dam-
age in workers. In the rodent model, TCE was observed to
produce bronchiolar damage when administered to mice
[30]. TCE is carcinogenic to the mouse lung and the tox-
icity is conﬁned to the accumulation of TCE metabolite in
non-ciliated Clara cells of the lung. Metabolic capacity of
lung determines the extent of toxicity of TCE in mouse
and human [31]. Pulmonary surfactant prevents alveolar
collapse at maximal expiration. Inhalation of TCE may  dam-
age the enzymes that are responsible for synthesizing the
pulmonary surfactant, resulting in lower amounts of sur-
factant being stored and available for secretion into the
alveolus [32].
In the present study effects of TCE on the cell cycle reg-
ulating genes in TCE-exposed workers were investigated.
None of the previous studies reported the possible role
of miRNA let-7c in regulation of PPARA gene expression
in lymphocytes of people occupationally exposed to TCE.
In this study we observed the effect of TCE exposure on
cell cycle regulating genes along with a possible mech-
anism of action and regulation of TCE metabolites in 49
TCE-exposed workers. We  examined exposure-related dif-
ferences in mRNA levels of p53, p21, bax, bcl2, p16 and
c-myc among individuals occupationally exposed to TCE
and controls. Various DNA-damaging agents that trigger
Table 4
Mean DHEAS hormone level with years of exposure to TCE.
Subjects Years of exposure
Control (n = 18) ≤5 years
(n = 13)
DHEAS (ng/mL) 3035.20
(2692.47–3207.40)
2334.20
(1738.39–3265.18)
Results are geometric mean. *p < 0.05, p-value compared with control group of wports 2 (2015) 748–757
programmed cell death also induce p53 expression. p53
mediated cell death may  involve activation or suppres-
sion of other genes like p21, bcl-2 and bax. Both p53 and
p21 play crucial roles in the DNA damage response. We
observed lower expression of mRNAs for p53 and p21
in the control group, whereas they were nearly twofold
up-regulated in the exposed individuals, suggesting DNA
damaging potential of TCE or its metabolites. An in vitro
study also reported elevated levels of p53 and Bax pro-
teins and a decreased level of Bcl-2 protein in TCE-treated,
p53-WT H460 cells [33]. A known p53 inducer, -radiation,
has been reported to decrease bcl-2 mRNA expression in
a human leukemia cell line [34]. TCE and its metabolites
TCA and DCA have been reported to decrease the meth-
ylation of promoter regions of the c-myc gene, leading to
an increased mRNA expression in the liver of B6C3F1 mice
[35]. In the present study there was  no signiﬁcant change
in the mRNA expression level of c-myc and p16 genes in the
TCE-exposed group. It would be difﬁcult to conclude that
TCE and/or its metabolites cause modulation in expression
of c-myc and p16 genes in human lymphocytes.
We  measured the levels of TCA and DCA in the blood of
both exposed and control groups through gas chromatog-
raphy using electron capture detection [28]. TCA and DCA
were present in detectable amounts in the exposed group.
Further, we observed no statistically signiﬁcant change in
the expression of PPARA transcript in the control and the
TCE-exposed groups. The TCE metabolites TCA and DCA are
weak PPARA ligands. They activate PPARA receptor; how-
ever, their binding afﬁnity is fairly low among all known
PPARA ligands [45]. Both metabolites are known to cause
hepatocarcinogenesis in rodent models through peroxi-
some proliferation and activation of the PPARA receptor.
Walgren et al. [1] investigated their impact on human
PPARA activation in cultured human hepatocytes and sug-
gested that humans may  not be susceptible to TCA- and
DCA-induced hepatocarcinogenesis. Numerous studies on
hepatocarcinogenesis caused by ligand activation of PPARA
showed that receptor speciﬁcity, species differences in
receptor activity, and relative ligand binding or activation
are the critical factors that inﬂuence the ligand or receptor
mediated effect [36,43]. There are no mechanistic stud-
ies that have reported a direct role of TCA and DCA in
modulating expression of the PPARA transcript in humans.
There may  be involvement of other downstream regulat-
ing factors. Therefore, we investigated the role of miRNAs
in its regulation. The let-7 family has been reported as a
tumor suppressor family of miRNAs [37,38]. qRT-PCR anal-
ysis showed up-regulation of miRNA let-7c in the exposed
group in comparison to the control group. It has been
reported that let-7 miRNA directly or indirectly regulates
5–10 years
(n = 8)
10–20 years
(n = 7)
20–40 years
(n = 7)
1822.81*
(709.3–2876.37)
1810.41*
(771.41–3396.01)
1767.32*
(947.26–3201.67)
orkers. Number in () refer to range.
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Fig. 3. Effect of trichloroethylene on DHEAS hormone level. (A) The decrease in DHEAS level in the blood of TCE exposed workers in comparison to control
is  shown (Mean ± SD). DHEAS level decreases to 2218.03 ± 698.3 ng/mL in TCE exposed group of workers in comparison to 3035.2 ± 195.8 ng/mL in control
g ed DHEA
a
m
u
i
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D
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ﬁ
[
e
v
h
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a
sroup  of workers. (B) The correlation between logarithmically transform
ge  is shown (p < 0.001, R = −0.50, Spearman, R2 = 0.25).
ultiple cell proliferation genes and let-7c is a key reg-
lator of cell cycle progression [39]. Thus, the potentially
mportant role of let-7c miRNA in control of fundamental
rocesses such as the cell cycle must be further investi-
ated.
TCA and DCA are known as exogenous PPARA ligands
hile DHEAS is an endogenous PPARA ligand in rodents.
HEAS is a naturally occurring adrenal steroid with known
eroxisome proliferation potential [22]. Therefore, we
easured DHEAS concentration in serum of the control
nd exposed group. Age of workers was signiﬁcantly and
egatively correlated with their DHEAS hormone level. Our
ndings are in conﬂict with those reported by Chia et al.
40], where occupational exposure to TCE was related to
levated levels of DHEAS in the serum of the workers. Pre-
ious studies hypothesized that the elevated level of DHEAS
ormone in TCE exposed people might be a result of pos-
ible competition between TCE metabolites and DHEAS
s ligands of the PPARA receptor [41]. The present study
howed that with increasing years of TCE exposure. DHEASS concentration (ng/mL) in the blood of TCE exposed workers and their
hormone level signiﬁcantly declined. Thus, a possibility of
DHEAS competition with TCA and DCA for binding to PPARA
receptor and its activation, if any, would diminish.
Results of the present study substantiate that occupa-
tional exposure to TCE causes respiratory ailments, which
is evident by the decline of pulmonary function. TCE expo-
sure also reduces body fat%. The study also supports the
association between TCE exposure and disturbances in cell
cycle regulation, which is indicated by increasing expres-
sion levels of p53, p21 and bax mRNAs together with
decreasing levels of bcl-2 mRNA. Nonetheless, involvement
of DHEAS as an endogenous ligand of PPARA is uncertain
in the observed changes in the levels of various mRNAs.
However, the signiﬁcant decrease in the DHEAS level of the
exposed workers in comparison to the controls indicates its
potential for endocrine disruption. Further, no difference
was observed in PPARA mRNA and let-7c miRNA expres-
sion in exposed workers. Further studies are essential to
explore the entire mechanism of TCE toxicity by attempting
additional human studies.
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